Prospective observational studies [19, 20] support associations of higher circulating CCL2 levels with ischemic stroke and cardiovascular death, whereas Mendelian randomization analyses from population genetic studies [21, 22] show associations with higher risk of ischemic stroke and coronary artery disease. The gene discussed is CCL2; the disease is ischemic stroke.